$ALLR Something to consider with NFA…. 03/02/26 $2OM 💰 NON-convert/NON-dilute financing is precisely structured to bridge the current Phase 2 (completion + strong data) through regulatory engagement and into pivotal escalation, with clear runway through 2028.
This setup creates an optimal window to pursue BTD (on top of existing 08/2025 Fast Track ) during the funded @US_FDA meeting prep phase, maximizing speed toward approval in platinum-resistant ovarian cancer.
BTD approval is 60 days ⏳⌛️🚀
Phase2 each treatment 28 days cycle.. do they have prep-data and that’s how 20M$ was approved ?
Who would agree to take 20M$ and just sit and wait with NO DATA and PLAN in MOTION…?
Any suggestions @BioValues @IAmBiotech
@IAmBiotech @BPharmCatalyst
@ESGO_society @myESMO
@PSOGI_EC
@IJGConline @ENYGO_official
@AJOG_thegray @gynoncjnls
@oncodaily
@JCO_ASCO @oncodaily
@AmgenOncology @OncoAlert @bioAffinity
4
28
3,850
WTec retweeted
Shorts = CIA
Exactly 6 years ago Roaring Kitty was explaining how the cost-to-borrow on $GME was going to bleed the 🩳s dry. Since then XRT has had a short interest well over 200% and been on regsho about half the time. Also at that time the person that Jeffrey Epstein emailed the most, Kathryn Ruemmler(who received the highest CIA award) was about to join the FINRA board of governors just in time to shut off the buy button.
Who were the loudest critics of GameStop? Jeffrey Epstein's closest friends High Bridge Capital CEO Glen Dubin, Melvin Capital Steven Cohen, and Loop Capital, which just so happens to be owned by Obama's brother in law. Kathy Ruemmler was Obama's Chief of Staff.
Do you see how it is all connected? They were all launder those shorted shares for the terrorist regime in Iran because they were untraceable. They were using the swift system but got hit with the biggest fines in 2017 when Trump got into office. What a coincidence right? Trump cuts off the swift system from them in 2017, then in 2020 he makes a plane to stop them moving dark money around through shorted shares.
We picked the right side! Patriots are in control!
WTec retweeted
Every now and then, someone says something that makes you stop and listen, words that land differently, linger in your mind, and remind you of what truly matters. In a world full of noise, those rare moments of real understanding are worth holding onto 🙏
WTec retweeted
Absolutely CRIMINAL
They invented 96,000 patients that never existed…got The Lancet to publish it…and used it to kill a cheap drug overnight…so they could get Emergency Use Authorization for the ‘Covid Vaccine’…
$FNGR @jolie_kahn CEO
$TBLT largely erased
$GCTK multiple RS
$OCEA delisted
$AVX multiple RS
$BBIG delisted and open @DOJ investigation
$FNGR work in progress 6$-0.03$
$GNS and many more are questionable…. info taken Straight from public records and findings thru @grok see below..
@FlyEaglesFly529 @kshaughnessy2
Jolie Kahn’s main public company roles:
Axion Power: GC; Ch. 7 bankruptcy 2018, liquidated.
ToughBuilt (TBLT): Interim CFO 2019-20; heavy dilution, reverse splits, long-term value largely erased.
GlucoTrack (GCTK): Interim CFO 2019-23; multiple reverse splits, major stock decline, still operating clinically.
Marathon Digital (MARA): GC 2019-23; grew into major BTC miner (strongest outcome).
Ocean Biomedical (OCEA): CFO 2024-25; Nasdaq delisted, now OTC sub-penny.
AVAX One/AgriFORCE (AVX): CEO 2024-26; AVAX treasury pivot + PIPE, exited mid-2026.
FingerMotion (FNGR): CEO since Aug 2026; ongoing AI/compute shift, stock down sharply.
Most microcaps showed typical sector dilution/declines; Marathon was the clear growth case.
WTec retweeted
Can we all now agree that Ham was nothing but a misleading dirtball the entire time?
$GTII $FNGR $GDC $MTEN $GBUX $ZJYL is quite a track record
Amazing what ppl will do for a dollar huh @bigmac_tx ?
To this day Ham is afraid to call out the CEO🤔
@kshaughnessy2
WTec retweeted
$FNGR
Thts classic
Instead of doing right by shareholders they go after their own shareholders
Nothing screams dirty like threatening your own shareholders when the stock is down 80% since the CEO came on board
#DirtyCorruptCEO
$FNGR
Is @FingerMotionInc sending cease and desist letters to shareholders who are asking for transparency and/or who question whether CEO @jolie_Kahn, a securities attorney, is fulfilling her fiduciary obligation?
@PCAOB_auditor
WTec retweeted
$FNGR
Is @FingerMotionInc sending cease and desist letters to shareholders who are asking for transparency and/or who question whether CEO @jolie_Kahn, a securities attorney, is fulfilling her fiduciary obligation?
@PCAOB_auditor
Replying to @kshaughnessy2
Correction - now $0.03 after another red flag trading event this morning for $FNGR
$ALLR great comparison and summary..
Good to point out it was originally developed by ImmunoGen (formerly $IMGN ) and AbbVie $ABBV acquired ImmunoGen in February 2024 for ~$10.1 billion ($31.26 per share in cash)
From 3$ 2023 to 31$ buyout 2024
Replying to @AllarityTx
@AllarityTx
$ALLR — ELAHERE's Success Story, Stenoparib's Expansion, and the Dr. Kathleen Moore Connection
There are some interesting parallels between ELAHERE's clinical development and Allarity Therapeutics' recent expansion of its Phase 2 stenoparib trial into three ovarian cancer patient cohorts.
1. ELAHERE: From Clinical Setback to FDA Approval
ELAHERE initially faced a major setback when its Phase 3 FORWARD I trial failed to meet its primary endpoint.
Rather than abandoning the program, ImmunoGen refined its patient-selection strategy, focusing on patients with high folate receptor alpha (FRα) expression.
The subsequent SORAYA trial demonstrated:
- Objective response rate (ORR): 31.7%
- Median duration of response (DOR): 6.9 months
- 104 evaluable patients
These results supported FDA accelerated approval in November 2022.
The larger Phase 3 MIRASOL trial later confirmed clinical benefit, leading to full FDA approval in March 2024.
2. The Kathleen Moore Connection
Perhaps the most interesting connection is that Dr. Kathleen N. Moore, a principal investigator of ELAHERE's pivotal MIRASOL trial, is also the principal investigator of Allarity's ongoing Phase 2 stenoparib trial.
Dr. Moore played an important role in ELAHERE's successful clinical development and is now helping lead stenoparib's investigation.
3. Why Allarity's Expansion Matters
On November 16, 2026, Allarity announced the expansion of its Phase 2 trial into three distinct ovarian cancer patient cohorts, including difficult-to-treat populations such as primary platinum-refractory patients.
Importantly, primary platinum-refractory patients were excluded from ELAHERE's pivotal SORAYA and MIRASOL trials.
If stenoparib demonstrates meaningful and durable responses in these challenging populations, it could potentially address an important unmet medical need.
Allarity has described its early clinical observations as encouraging and highlighted investigator support for the expansion.
4. Previous Stenoparib Clinical Signals
Allarity has previously reported:
- Approximately 22 months of median overall survival in an earlier cohort
- A confirmed complete response in a heavily pretreated patient
- Prolonged treatment and survival observations in individual patients
These findings are preliminary and cannot be directly compared with ELAHERE's larger clinical studies.
5. My Perspective
ELAHERE demonstrated how identifying the right patient population through biomarker-guided selection can transform a drug's development.
Allarity is pursuing a related precision-oncology strategy through its DRP® platform.
Three factors stand out to me:
- The expansion into additional, difficult-to-treat ovarian cancer populations.
- Management's description of early findings as encouraging, alongside investigator support.
- Dr. Kathleen Moore's involvement in both ELAHERE's successful MIRASOL trial and stenoparib's ongoing Phase 2 study.
None of these guarantees success. Strong ORR, DOR, safety, and DRP® validation data are still needed.
However, if stenoparib demonstrates durable efficacy across these challenging patient populations, its clinical and commercial potential could become significantly more compelling.
ELAHERE showed what the right patient-selection strategy can achieve. Now it's stenoparib's turn to prove its potential through clinical data.
$ALLR
13
785
$ALLR @AllarityTx secure US #patent for #stenoparib supports the dosing strategy used in its ongoing Phase 2 program.
“The commercial significance of this patent is enormous. Its coverage of our twice-daily dosing strategy is critical as this is the dosing regimen we intend to advance to pivotal trials,” CEO
@uspto
2
18
1,054
Replying to @RabbiJeffx
TRUE
Maria Farmer stated in 2020 interviews (The Sun and others) that Maxwell showed her photos of royals including Diana and said those exact words while laughing. A journalist who knew Maxwell also recalled her joking about making Diana cry. Uncorroborated beyond Farmer’s account.
Replying to @BasedSamParker
US rate ~13.7/100k. Combined NSA + CyberCom workforce is roughly 40-50k (NSA ~30-40k post-cuts; CyberCom several thousand). Expected annual suicides: ~5.5-7.
11 in a year is elevated (~1.5-2x baseline). Under Poisson, P(≥11 | λ=6) is a few percent.
5 in one month (λ_month ~0.5) has probability ~0.01% or lower—highly unusual under baseline rates, consistent with the reported cluster drawing official attention. High-stress classified work and military rates raise the expected baseline somewhat.
$ALLR @AllarityTx it appears that companies wouldnt start prep-Phase 3 without encouraging Phase 2 efficacy and safety signals…
Still waiting on phase 2 updates…
In meantime phase-3 coming ⏳⌛️
2
16
1,465
WTec retweeted
🇵🇱 Poland celebrates 108 years of INDEPENDENCE today!
As every year, tens of thousands of patriotic Poles took to the streets to participate in the Polish Independence Day March.
No matter how much pressure the EU puts on Poland, the Polish people will never surrender their sovereignty or sell out their country. 🇵🇱
WTec retweeted
🇵🇱 108 years ago today, Poles reclaimed their country.
For 123 years, they didn't have one. It was partitioned and picked apart by Prussia, Russia, Germany, and Austria throughout much of its recent history.
But in the 13th of U.S. President Woodrow Wilson's Fourteen Points, drawn up at the end of WWI, Poland's independence was written in as a requirement.
Under communist rule, Independence Day was banned, returning only in 1989 as the USSR's influence waned.
Today, Poles celebrate a holiday they used to not be allowed to celebrate in a country that was lost to them for more than a century.
And this year, after all that's happened in Poland just in the past few weeks, with a constitutional crisis and a horrific tragedy in Kraków, it means all the more.
Happy Independence Day, Poland. You earned it. 🇵🇱❤️
Writer: Michael
WTec retweeted
👇
🚨CALL TO ACTION
Let's get the 🩼-🦆 Congress to pass this 1-word amendment to end settlement fails before they leave. I'll post draft legislation to Ko-Fi soon. Dates they are in district offices are marked on this calendar.
house.gov/legislative-activi…
WTec retweeted
🚨CALL TO ACTION
Let's get the 🩼-🦆 Congress to pass this 1-word amendment to end settlement fails before they leave. I'll post draft legislation to Ko-Fi soon. Dates they are in district offices are marked on this calendar.
house.gov/legislative-activi…
WTec retweeted
$GNS
@rogerhamilton couldn't even use the term "reverse split" in his BS tweet
"share consolidation to support" 😂😂🤦♂️
So, I fixed it for you Roger
Hey Roger, whats more "abusive", misleading shareholders and your stock 7cts or shareholder asking hard Qs?
@kshaughnessy2























